Upcoming event

Masterclass on Non-muscle-invasive bladder cancer

Home / Randomized phase III trial of dose-dense MVAC or GC as perioperative chemotherapy for muscle-invasive urothelial bladder cancer (MIUBC): Preliminary results of the GETUG/AFU V05 VESPER trial on toxicity and pathological responses

Back

Randomized phase III trial of dose-dense MVAC or GC as perioperative chemotherapy for muscle-invasive urothelial bladder cancer (MIUBC): Preliminary results of the GETUG/AFU V05 VESPER trial on toxicity and pathological responses

Pfister C.,
Gravis G.,
Flechon A.,
Soulie M.,
Guy L.,
Laguerre B.,
Mottet N.,
Joly F.,
Allory Y.,
Harter V.,
Culine S.,
GETUG AFU V05 Investigators